BACKGROUND: The endothelial glycocalyx layer (EGL) coats the alveolar capillary endothelium and plays important roles in pulmonary vascular protection, modulation, and hemostasis. Ischemia-reperfusion, which occurs during lung resection surgery with one lung ventilation (OLV), can damage the EGL. Sevoflurane is known for its protective effect against ischemia-reperfusion injury. Therefore, we hypothesized that lung resection surgery produces EGL damage and sevoflurane protects the EGL better than the intravenous anesthetic propofol. METHODS: Seventy-eight patients undergoing pulmonary resection were randomly allocated into the sevoflurane (n=38) and propofol (n=40) groups. All patients received OLV and protective ventilation under sevoflurane- or propofol-based anesthesia. The concentrations of EGL injury markers (heparan sulfate and human syndecan-1) and an inflammatory marker (vascular cell adhesion molecule-1) were measured from blood samples drawn at five time points (after induction, 60 min after OLV, 120 min after OLV, end of OLV, and end of surgery). RESULTS: OLV increased the concentrations of EGL injury markers; heparan sulfate concentrations increased from 120 minutes after OLV (120 minutes after OLV: sevoflurane, 13.3±6.8 ng/mL, P<0.05; propofol, 14.8±6.9 ng/mL, P<0.05). Human syndecan-1 concentrations also increased from 120 minutes after OLV (120 minutes after OLV: sevoflurane, 20.4±8.9 ng/mL, P<0.05; propofol, 20.5±11.8 ng/mL, P>0.05). However, no difference in EGL injury markers was observed between the sevoflurane and propofol groups at any time point. Vascular cell adhesion molecule-1 concentrations did not show any temporal changes in either group. CONCLUSIONS: Lung resection surgery with OLV produced EGL damage without any increase in inflammation. Although shedding of heparan sulfate induced by EGL injury during lung resection surgery with OLV, was less than propofol, it was not statistically significant.
BACKGROUND: The endothelial glycocalyx layer (EGL) coats the alveolar capillary endothelium and plays important roles in pulmonary vascular protection, modulation, and hemostasis. Ischemia-reperfusion, which occurs during lung resection surgery with one lung ventilation (OLV), can damage the EGL. Sevoflurane is known for its protective effect against ischemia-reperfusion injury. Therefore, we hypothesized that lung resection surgery produces EGL damage and sevoflurane protects the EGL better than the intravenous anesthetic propofol. METHODS: Seventy-eight patients undergoing pulmonary resection were randomly allocated into the sevoflurane (n=38) and propofol (n=40) groups. All patients received OLV and protective ventilation under sevoflurane- or propofol-based anesthesia. The concentrations of EGL injury markers (heparan sulfate and human syndecan-1) and an inflammatory marker (vascular cell adhesion molecule-1) were measured from blood samples drawn at five time points (after induction, 60 min after OLV, 120 min after OLV, end of OLV, and end of surgery). RESULTS: OLV increased the concentrations of EGL injury markers; heparan sulfate concentrations increased from 120 minutes after OLV (120 minutes after OLV: sevoflurane, 13.3±6.8 ng/mL, P<0.05; propofol, 14.8±6.9 ng/mL, P<0.05). Human syndecan-1 concentrations also increased from 120 minutes after OLV (120 minutes after OLV: sevoflurane, 20.4±8.9 ng/mL, P<0.05; propofol, 20.5±11.8 ng/mL, P>0.05). However, no difference in EGL injury markers was observed between the sevoflurane and propofol groups at any time point. Vascular cell adhesion molecule-1 concentrations did not show any temporal changes in either group. CONCLUSIONS: Lung resection surgery with OLV produced EGL damage without any increase in inflammation. Although shedding of heparan sulfate induced by EGL injury during lung resection surgery with OLV, was less than propofol, it was not statistically significant.
Authors: Marc J Licker; Igor Widikker; John Robert; Jean-George Frey; Anastase Spiliopoulos; Christoph Ellenberger; Alexandre Schweizer; Jean-Marie Tschopp Journal: Ann Thorac Surg Date: 2006-05 Impact factor: 4.330
Authors: Bernhard F Becker; Daniel Chappell; Dirk Bruegger; Thorsten Annecke; Matthias Jacob Journal: Cardiovasc Res Date: 2010-05-11 Impact factor: 10.787
Authors: Sietze Reitsma; Dick W Slaaf; Hans Vink; Marc A M J van Zandvoort; Mirjam G A oude Egbrink Journal: Pflugers Arch Date: 2007-01-26 Impact factor: 3.657
Authors: T Annecke; D Chappell; C Chen; M Jacob; U Welsch; C P Sommerhoff; M Rehm; P F Conzen; B F Becker Journal: Br J Anaesth Date: 2010-02-19 Impact factor: 9.166
Authors: Markus Rehm; Dirk Bruegger; Frank Christ; Peter Conzen; Manfred Thiel; Matthias Jacob; Daniel Chappell; Mechthild Stoeckelhuber; Ulrich Welsch; Bruno Reichart; Klaus Peter; Bernhard F Becker Journal: Circulation Date: 2007-10-08 Impact factor: 29.690
Authors: Elaheh Rahbar; Jessica C Cardenas; Gyulnar Baimukanova; Benjamin Usadi; Roberta Bruhn; Shibani Pati; Sisse R Ostrowski; Pär I Johansson; John B Holcomb; Charles E Wade Journal: J Transl Med Date: 2015-04-12 Impact factor: 5.531
Authors: Timothy M Sladden; Stephanie Yerkovich; Douglas Wall; Maxine Tan; William Hunt; Jonathan Hill; Ian Smith; Peter Hopkins; Daniel C Chambers Journal: J Transplant Date: 2019-08-25
Authors: Chung-Sik Oh; Ji Min Choi; Eun Hi Park; Liyun Piao; Hyun-Jun Park; Ka-Young Rhee; Seong-Hyop Kim Journal: Biomed Res Int Date: 2021-01-23 Impact factor: 3.411
Authors: Na Young Kim; Ki Jun Kim; Ki-Young Lee; Hye Jung Shin; Jaein Cho; Da Jeong Nam; So Yeon Kim Journal: Sci Rep Date: 2021-01-15 Impact factor: 4.379
Authors: Manuel F Struck; Gunther Hempel; Uta C Pietsch; Johannes Broschewitz; Uwe Eichfeld; Robert Werdehausen; Sebastian Krämer Journal: BMC Anesthesiol Date: 2019-10-27 Impact factor: 2.217